Squamous cell carcinomas (SCC) are the most common malignant tumors that arise in the
head and neck. Despite advances in the management of affected patients, the mortality …

OBJECTIVES: To report the long-term outcome and toxicity of locoregionally advanced
nasopharyngeal carcinoma (LA NPC) treated with nimotuzumab (h-R3) plus intensity …

Oral tongue squamous cell carcinoma (OTSCC) stands as the most common malignancy in
the oral cavity. It is characterized by its aggressive course and has the worst prognosis of all …

The expansion in understanding the molecular biology that characterizes cancer cells has
led to the rapid development of new agents to target important molecular pathways …

Purpose The efficacy and safety of nimotuzumab (NTZ) added to concurrent
chemoradiotherapy (CCRT) were investigated in patients with stage III–IVa nasopharyngeal …

Precision medicine is a new strategy that aims at preventing and treating human diseases
by focusing on individual variations in people's genes, environment and lifestyle. Precision …

Pneumatosis intestinalis, defined as gas in the bowel wall, is often first identified on
abdominal radiographs or computed tomography (CT) scans. It is a radiographic finding and …

In this retrospective review of a single institution's experience, the efficacy and safety of the
long-term use of nimotuzumab in combination with intensity-modulated radiotherapy (IMRT) …

Although the receptor tyrosine kinase (RTK) MET is widely expressed in head and neck
squamous cell carcinoma (HNSCC), its prognostic value remains unclear. This might be due …

The anti-EGFR antibody Nimotuzumab was radioiodinated with I-131 by Chloramine T and
Iodogen methods. The 131 I-Nimotuzumab was purified and characterized by HPLC …